Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Canadian Computed Tomography (CT) Head Rule Study

Phase 3

Completed

Conditions: Head Injury

First Posted Date: 2009-10-12

Last Posted Date: 2010-10-15

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 4531

Registration Number: NCT00993252

Locations: 🇨🇦
Royal Columbian Hospital, Westminster, British Columbia, Canada
🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada

and more 7 locations

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Phase 4

Completed

Conditions: Idiopathic Venous Thromboembolism

Interventions: Other: Application of the"Men continue and HER DOO2" rule

First Posted Date: 2009-08-27

Last Posted Date: 2016-09-01

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 2779

Registration Number: NCT00967304

Locations: 🇺🇸
Penobscot Bay Medical Center, Rockport, Maine, United States
🇺🇸
UC Davis, Santa Monica, California, United States
🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia

and more 20 locations

Impact of Chronic Statin Use During Surgery on Inflammation and Infection Rates

Completed

Conditions: Inflammation
Infection
Endothelial Function

Interventions: Other: Control
Drug: Atorvastatin

First Posted Date: 2009-08-27

Last Posted Date: 2011-07-21

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 50

Registration Number: NCT00967252

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Statin Drugs to Prevent Complications During Surgery

Not Applicable

Completed

Conditions: Inflammation
Myocardial Infarction
Myocardial Ischemia

Interventions: Drug: Placebo
Drug: Atorvastatin

First Posted Date: 2009-08-27

Last Posted Date: 2018-06-12

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 60

Registration Number: NCT00967434

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

Phase 3

Completed

Conditions: Pregnancy
Thrombophilia
Pregnancy Complications

Interventions: Drug: dalteparin sodium

First Posted Date: 2009-08-27

Last Posted Date: 2014-05-19

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 292

Registration Number: NCT00967382

Locations: 🇨🇦
SMBD Jewish General Hospital, Montreal, Quebec, Canada
🇨🇦
Royal University Hospital, Saskatoon, Saskatchewan, Canada
🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada

and more 9 locations

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Phase 1

Completed

Conditions: Non-Small Cell Lung Cancer
Squamous Cell Carcinoma

Interventions: Drug: Erlotinib + Rosuvastatin

First Posted Date: 2009-08-27

Last Posted Date: 2020-04-21

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 24

Registration Number: NCT00966472

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

Motion Analysis of EMP Knee Versus Posterior Stabilized Knee Arthroplasty for Osteoarthritis

Not Applicable

Completed

Conditions: Arthropathy of Knee Joint

Interventions: Procedure: Total Knee Arthroplasty
Procedure: Motion analysis

First Posted Date: 2009-08-27

Last Posted Date: 2015-11-18

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 50

Registration Number: NCT00967161

Locations: 🇨🇦
The Ottawa General Hospital, Ottawa, Ontario, Canada

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

Not Applicable

Completed

Conditions: Pulmonary Embolism
Deep Vein Thrombosis
Cancer

Interventions: Drug: Tinzaparin

First Posted Date: 2009-08-27

Last Posted Date: 2014-10-22

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 18

Registration Number: NCT00967148

Locations: 🇨🇦
Ottawa Health Research Institute, Ottawa, Ontario, Canada

The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial

Phase 2

Active, not recruiting

Conditions: Anterior Wall Myocardial Infarction

Interventions: Biological: Autologous EPCs
Biological: Autologous EPCs Transfected with human eNOS
Biological: Plasma-Lyte A and 25% Autologous Plasma

First Posted Date: 2009-07-10

Last Posted Date: 2020-12-02

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 47

Registration Number: NCT00936819

Locations: 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦
L'institut de cardiologie de Montreal, Montreal, Quebec, Canada

and more 1 locations

Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?

Completed

Conditions: Delirium
Postoperative Cognitive Dysfunction

First Posted Date: 2009-06-02

Last Posted Date: 2009-06-02

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 100

Registration Number: NCT00911677

Locations: 🇨🇦
The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy